IMV Inc【IMV】株式ニュース

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

Horizon Technology Finance Announces First Quarter 2023 Financial Results

Horizon Technology Finance Announces First Quarter 2023 Financial Results PR Newswire FARMINGTON, Conn., May 2, 2023 - First Quarter 2023 Net...

IMV fournit une mise à jour sur son programme de vaccin COVID-19

Sélectionnée par le gouvernement canadien pour recevoir un financement supplémentaire, portant le soutien à un total de 10 millions de dollars à...

IMV to Participate at Four Upcoming Investor Conferences

IMV Inc. (“IMV” or the “Corporation”) (Nasdaq: IMV; TSX: IMV), a clinical-stage biopharmaceutical company pioneering a novel class of cancer...

IMV Inc. Announces Second Quarter 2020 Financial Results

Rapidly progressing DPX-COVID-19, including Health Canada agreement on Phase 1 clinical study design protocol, with preliminary results expected...

IMV reçoit des subventions de la part d’agences gouvernementales pour la phase 1 du développement clinique du vaccin cont...

Ces subventions d’un total de 4,75 millions soutiendront la fabrication du vaccin et l’étude clinique de phase 1 IMV Inc. (Nasdaq: IMV; TSX:...

IMV Receives Funding From Canadian Governmental Agencies for COVID-19 Vaccine Phase 1 Clinical Study

Contribution totalling Cdn$4.75 Million will support Phase 1 clinical development and manufacturing of DPX-COVID-19 IMV Inc. (Nasdaq: IMV; TSX:...

IMV Inc. to Announce Second Quarter 2020 Results and Host a Conference Call and Webcast on August 12, 2020

IMV Inc. (“IMV” or the “Corporation”) (Nasdaq: IMV; TSX: IMV), a clinical-stage biopharmaceutical company pioneering a novel class of cancer...

IMV to Present at BTIG’s Virtual Biotechnology Conference

IMV Inc. (Nasdaq: IMV; TSX: IMV), a clinical-stage biopharmaceutical company pioneering a novel class of immunotherapies, today announced that...

IMV Announces Appointment of Michael P. Bailey to Board of Directors

IMV Inc. (Nasdaq: IMV; TSX: IMV), a clinical-stage biopharmaceutical company pioneering a novel class of cancer immunotherapies and vaccines...

IMV annonce une mise-à-jour des progrès rapides de son programme de développement de son vaccin candidat contre la COVID-19

Reçoit l’accord de Santé Canada à l’égard du design d’un essai clinique de phase 1, lequel comprendra aussi une cohorte d'adultes âgés de 56 ans...

IMV Announces Leading Independent Proxy Advisory Firms Recommend Shareholders Vote FOR All Resolutions at Upcoming Annual & S...

IMV Inc. (“IMV” or the “Company”) (Nasdaq: IMV; TSX: IMV), is pleased to announce that Institutional Shareholder Services Inc. (“ISS”) and Glass...

市場データ

ニュース

投資ツール

市場

発見

Hot Features

Follow Feed

ライブオプションフロー

モニター

IMV Inc (IMV)

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

IMV Inc (IMV) ニュース

Horizon Technology Finance Announces First Quarter 2023 Financial Results

IMV fournit une mise à jour sur son programme de vaccin COVID-19

IMV to Participate at Four Upcoming Investor Conferences

IMV Inc. Announces Second Quarter 2020 Financial Results

IMV reçoit des subventions de la part d’agences gouvernementales pour la phase 1 du développement clinique du vaccin cont...

IMV Receives Funding From Canadian Governmental Agencies for COVID-19 Vaccine Phase 1 Clinical Study

IMV Inc. to Announce Second Quarter 2020 Results and Host a Conference Call and Webcast on August 12, 2020

IMV to Present at BTIG’s Virtual Biotechnology Conference

IMV Announces Appointment of Michael P. Bailey to Board of Directors

IMV annonce une mise-à-jour des progrès rapides de son programme de développement de son vaccin candidat contre la COVID-19

IMV Updates Rapid Progress on COVID-19 Vaccine Program

IMV maintains the remainder of its At-the-Market Facility under its new Base Shelf Prospectus

IMV Announces Annual and Special Meeting of Shareholders Voting Results

IMV Files Preliminary Base Shelf Prospectus to Replace Expiring Base Shelf Prospectus

IMV Announces Leading Independent Proxy Advisory Firms Recommend Shareholders Vote FOR All Resolutions at Upcoming Annual & S...

IMV Discussion

最近閲覧した銘柄

会社情報

ビジネス

人気

アプリを入手

市場データ

ニュース

投資ツール

市場

発見

Hot Features

Follow Feed

ライブオプションフロー

モニター

IMV Inc (IMV)

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

IMV Inc (IMV) ニュース

Horizon Technology Finance Announces First Quarter 2023 Financial Results

IMV fournit une mise à jour sur son programme de vaccin COVID-19

IMV to Participate at Four Upcoming Investor Conferences

IMV Inc. Announces Second Quarter 2020 Financial Results

IMV reçoit des subventions de la part d’agences gouvernementales pour la phase 1 du développement clinique du vaccin cont...

IMV Receives Funding From Canadian Governmental Agencies for COVID-19 Vaccine Phase 1 Clinical Study

IMV Inc. to Announce Second Quarter 2020 Results and Host a Conference Call and Webcast on August 12, 2020

IMV to Present at BTIG’s Virtual Biotechnology Conference

IMV Announces Appointment of Michael P. Bailey to Board of Directors

IMV annonce une mise-à-jour des progrès rapides de son programme de développement de son vaccin candidat contre la COVID-19

IMV Updates Rapid Progress on COVID-19 Vaccine Program

IMV maintains the remainder of its At-the-Market Facility under its new Base Shelf Prospectus

IMV Announces Annual and Special Meeting of Shareholders Voting Results

IMV Files Preliminary Base Shelf Prospectus to Replace Expiring Base Shelf Prospectus

IMV Announces Leading Independent Proxy Advisory Firms Recommend Shareholders Vote FOR All Resolutions at Upcoming Annual & S...

IMV Discussion

最近閲覧した銘柄

会社情報

ビジネス

人気

アプリを入手

無料で登録してください:

広告を削除する